
|Articles|July 31, 2001
Viewpoint: The business of pharmaceuticals
Prescription drug expenditures. Richard Markham, CEO of Aventis Pharmaceuticals.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
The trend toward post-infusion outpatient care of patients treated with CAR-T | ASH 2025
2
Sanofi’s Qfitlia seems favorable for hemophilia with easier dosing and broad coverage | ASH 2025
3
Immunotherapy combination of teclistamab and daratumumab heralded as potential 'functional cure' for multiple myeloma | ASH 2025
4
2025 FDA dermatology approvals: A new gene therapy and two targeted therapies
5





















































